Vaccines/Infectious Disease | Yale Ventures

Vaccines/Infectious Disease

Potent Anti-Virulence Factor Against MRSA

Phage Therapy for Restoring Antibiotic Sensitivity to Bacterial Pathogens

TLR-7-Based HIV Therapeutic

Anti-HIV Agents

Host-directed therapeutics against highly pathogenic coronaviruses including SARS-CoV-2

Intron Therapeutics: Targeting the Unique Features of Fungal Metabolism to Build a New Generation of Nontoxic Drugs

RIGImmune: Harnessing the Innate Immune System

Brett Lindenbach

Biosafe SARS-CoV-2 Replicons for High-Throughput Screening

Guo Head Shot

Discovery and Optimization of Novel Compounds Targeting Programmed Ribosomal Frameshifting in RNA Viruses

Vinetz Head Shot

Development of camostat-related compounds for COVID-19 and other coronavirus infections

Subscribe to Vaccines/Infectious Disease